Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer. (Q51798899)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

Ninke Leffers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Marloes J M Gooden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Anna A Mokhova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

H Marike Boezen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Klaske A Ten Hoor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Harry Hollema

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ate G J van der Zee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Hans W Nijman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

English

0 references

publication date

24 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

256-263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19243813%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Immunotherapy for gynaecological malignancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Epithelial ovarian cancer: a review of current management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Sperm protein 17 is a suitable target for adoptive T-cell-based immunotherapy in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Antigen presentation machinery (APM) modulation and soluble HLA molecules in the tumor microenvironment: do they provide tumor cells with escape mechanisms from recognition by cytotoxic T lymphocytes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Antigen-processing machinery breakdown and tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Structure and functions of the 20S and 26S proteasomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Proteasome and peptidase function in MHC-class-I-mediated antigen presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Molecular machinations of the MHC-I peptide loading complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Proteasome function in antigen presentation: immunoproteasome complexes, Peptide production, and interactions with viral proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Role of proteasomes in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Accessory molecules in the assembly of major histocompatibility complex class I/peptide complexes: how essential are they for CD8(+) T-cell immune responses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

HLA antigen changes in malignant tumors of mammary epithelial origin: molecular mechanisms and clinical implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Haplotype loss of HLA class I antigen as an escape mechanism from immune attack in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Validation of tissue microarray technology in breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Validation of tissue microarray technology in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 Concerted Action on Clinical Relevance of Proteases in Tumour Invasion and Metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Prognostic significance of immuno-proteosome subunit expression in patients with renal-cell carcinoma: a preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.030